Abstract:The ubiquitin-proteasome system (UPS) is a catalytic machinery that targets numerous cellular proteins for degradation, thus being essential to control a wide range of basic cellular processes and cell survival. Degradation of intracellular proteins via the UPS is a tightly regulated process initiated by tagging a target protein with a specific ubiquitin chain. Neurons are particularly vulnerable to any change in protein composition, and therefore the UPS is a key regulator of neuronal physiology. Alterations in UPS activity may induce pathological responses, ultimately leading to neuronal cell death. Brain ischemia triggers a complex series of biochemical and molecular mechanisms, such as an inflammatory response, an exacerbated production of misfolded and oxidized proteins, due to oxidative stress, and the breakdown of cellular integrity mainly mediated by excitotoxic glutamatergic signaling. Brain ischemia also damages protein degradation pathways which, together with the overproduction of damaged proteins and consequent upregulation of ubiquitin-conjugated proteins, contribute to the accumulation of ubiquitin-containing proteinaceous deposits. Despite recent advances, the factors leading to deposition of such aggregates after cerebral ischemic injury remain poorly understood. This review discusses the current knowledge on the role of the UPS in brain function and the molecular mechanisms contributing to UPS dysfunction in brain ischemia with consequent accumulation of ubiquitin-containing proteins. Chemical inhibitors of the proteasome and small molecule inhibitors of deubiquitinating enzymes, which promote the degradation of proteins by the proteasome, were both shown to provide neuroprotection in brain ischemia, and this apparent contradiction is also discussed in this review.

SUMOylation in brain ischemia: Patterns, targets, and translational implications

SUMOtherapeutics for Ischemic Stroke

SUMOylation in Neurological Diseases

SUMOylation as a Therapeutic Target for Myocardial Infarction

Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response

Role of the ubiquitin–proteasome system in brain ischemia: Friend or foe?

Role of Pericyte‐derived SENP1 in Neuronal Injury after Brain Ischemia

SUMOylation: A Link to Future Therapeutics.

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

Mechanistic exploration of ubiquitination-mediated pathways in cerebral ischemic injury

SUMO regulation of ion channels in health and disease

The Role of SUMOylation in the Neurovascular Dysfunction after Acquired Brain Injury

Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity

Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease

Research progress of small ubiquitin-related modifierylation in the regeneration of spinal cord injury

Role of SUMOylation in Neurodegenerative Diseases

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

SUMO-specific Protease 1 Protects Neurons from Apoptotic Death During Transient Brain Ischemia/reperfusion

The role of SUMO specific peptidase 3 in secondary inflammation of ischemic stroke in mice

Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation

Sumoylation-Mediated Response To Mitochondrial Stress